ArticleAnnals of translational medicine2025

Dapagliflozin enhances gut barrier function in rats with chronic myocardial infarction by modulating gut microbiota balance.

Chanon Kunasol et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.